These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30104527)

  • 1. Chalcones Repressed the AURKA and MDR Proteins Involved in Metastasis and Multiple Drug Resistance in Breast Cancer Cell Lines.
    Komoto TT; Bernardes TM; Mesquita TB; Bortolotto LFB; Silva G; Bitencourt TA; Baek SJ; Marins M; Fachin AL
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30104527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein.
    Liu XL; Tee HW; Go ML
    Bioorg Med Chem; 2008 Jan; 16(1):171-80. PubMed ID: 17964170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity.
    Coley HM; Labeed FH; Thomas H; Hughes MP
    Biochim Biophys Acta; 2007 Apr; 1770(4):601-8. PubMed ID: 17270349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest.
    Bortolotto LF; Barbosa FR; Silva G; Bitencourt TA; Beleboni RO; Baek SJ; Marins M; Fachin AL
    Biomed Pharmacother; 2017 Jan; 85():425-433. PubMed ID: 27903423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.
    Liu F; Fan D; Qi J; Zhu H; Zhou Y; Yang C; Zhu Z; Xiong D
    Life Sci; 2008 Sep; 83(13-14):496-501. PubMed ID: 18725232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analogues.
    Han Y; Riwanto M; Go ML; Ee PL
    Eur J Pharm Sci; 2008 Sep; 35(1-2):30-41. PubMed ID: 18598762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.
    Thrane S; Pedersen AM; Thomsen MB; Kirkegaard T; Rasmussen BB; Duun-Henriksen AK; Lænkholm AV; Bak M; Lykkesfeldt AE; Yde CW
    Oncogene; 2015 Aug; 34(32):4199-210. PubMed ID: 25362855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.
    Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT
    Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.
    Juvale K; Pape VF; Wiese M
    Bioorg Med Chem; 2012 Jan; 20(1):346-55. PubMed ID: 22112540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graphene Quantum Dots Downregulate Multiple Multidrug-Resistant Genes via Interacting with Their C-Rich Promoters.
    Luo C; Li Y; Guo L; Zhang F; Liu H; Zhang J; Zheng J; Zhang J; Guo S
    Adv Healthc Mater; 2017 Nov; 6(21):. PubMed ID: 28748603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
    Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
    Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.
    Hunyadi A; Csábi J; Martins A; Molnár J; Balázs A; Tóth G
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28125071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity.
    Hermawan A; Wagner E; Roidl A
    Oncol Rep; 2016 Mar; 35(3):1732-40. PubMed ID: 26708059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway.
    Wang F; Lv P; Gu Y; Li L; Ge X; Guo G
    Oncotarget; 2017 Apr; 8(15):25097-25106. PubMed ID: 28212576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
    Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.
    Scala S; Budillon A; Zhan Z; Cho-Chung YS; Jefferson J; Tsokos M; Bates SE
    J Clin Invest; 1995 Aug; 96(2):1026-34. PubMed ID: 7543490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
    Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.